The Clot Thickens: COVID-19-Related ST-Elevation Myocardial Infarction in the Setting of Recent Boosters
Amar R Patel1, Kunal Mishra2, Andrew J Ortega3
1Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, USA.
Insights
This case report details a COVID-19 patient who experienced ST-elevated myocardial infarction (STEMI) after a booster vaccine. It highlights the complex thrombotic risks from combined COVID-19 infection and vaccination.
Area of Science:
- Cardiology
- Infectious Diseases
- Vaccinology
Background:
- Coronavirus disease 2019 (COVID-19) presents diverse pathological effects.
- COVID-19 vaccines are primary tools, but their thrombotic risks, especially combined with infection, require further study.
- ST-elevated myocardial infarction (STEMI) is a serious cardiac event.
Observation:
- A patient with recent COVID-19 diagnosis received a booster vaccination.
- The patient subsequently developed STEMI.
- This case explores the thrombotic burden in a COVID-19-associated STEMI scenario.
Findings:
- The case illustrates a potential cumulative pro-thrombotic effect.
- This effect may arise from concomitant symptomatic COVID-19 infection and a recent COVID-19 booster.
- Treatment outcomes for COVID-19-associated clots were reviewed.
Implications:
- Understanding the complex interplay between COVID-19 infection, vaccination, and thrombotic events like STEMI is crucial.
- This case emphasizes the need for vigilance regarding cardiovascular risks in patients with recent COVID-19 and vaccination.
- Further research is warranted to establish the definitive thrombotic risks associated with combined COVID-19 infection and vaccination.
Abstract:
The coronavirus disease of 2019 (COVID-19) has an array of pathological effects that continue to be discovered. Vaccines against COVID-19 have quickly emerged as our main tool. However, the thrombotic risk of both the virus and the vaccine is yet to be established, let alone together. In this case report, we present a case involving a recently diagnosed COVID-19 patient who developed an ST-elevated myocardial infarction (STEMI) after receiving his booster shot. Our aim is to highlight the standard of treatment outcomes in COVID-19-associated clots, familiarize ourselves with the complexity of the clot burden in a COVID-19-associated STEMI, and illustrate the potential role of the cumulative pro-thrombotic effects of a recent COVID-19 booster with a concomitant symptomatic COVID-19 infection.
More Related Videos
07:40Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
Published on: October 10, 2019
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Related Concept Videos
Myocarditis III: Medical Management
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Myocarditis I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Myocarditis II: Clinical Features and Diagnostic Tests
